OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
The gut microbiota–brain axis in neurological disorders
Mingming You, Nan Chen, Yuanyuan Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 14
Mingming You, Nan Chen, Yuanyuan Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 14
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation
Imanuel Lerman, Yifeng Bu, Rahul Singh, et al.
Bioelectronic Medicine (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Imanuel Lerman, Yifeng Bu, Rahul Singh, et al.
Bioelectronic Medicine (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access | Times Cited: 1
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access | Times Cited: 1
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Curli protein: A potential contributor to α-synucleopathy in Parkinson's disease
Nabanita Ghosh, Krishnendu Sinha
Translational Medicine of Aging (2025) Vol. 9, pp. 41-48
Open Access
Nabanita Ghosh, Krishnendu Sinha
Translational Medicine of Aging (2025) Vol. 9, pp. 41-48
Open Access
Protective effect of ginsenoside CK against MPTP-induced Parkinson’ s disease mouse model by suppressing oxidative stress and inflammation, and modulating the gut microbiota
Yang Xu, Yuting Zhao, Lily Liang, et al.
Microbial Pathogenesis (2025), pp. 107409-107409
Closed Access
Yang Xu, Yuting Zhao, Lily Liang, et al.
Microbial Pathogenesis (2025), pp. 107409-107409
Closed Access
Impact of Ulcerative Colitis on Parkinson’s Disease: A Study on Gut Inflammation, Barrier Dysfunction, and Neuroinflammation
祥云 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1210-1217
Closed Access
祥云 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1210-1217
Closed Access
Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility
Liu Li, Yan Zhao, Weixing Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2079-2079
Open Access
Liu Li, Yan Zhao, Weixing Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2079-2079
Open Access
A 3D Gut-Brain-Vascular Platform for Bidirectional Crosstalk in Gut-Neuropathogenesis
Hansang Cho, Minh Tran, Haksan Jeong, et al.
(2025)
Closed Access
Hansang Cho, Minh Tran, Haksan Jeong, et al.
(2025)
Closed Access
Enteric nervous system dysfunction as a driver of central nervous system disorders: The Forgotten brain in neurological disease
Orabi Hajjeh, Islam Rajab, Mohammad Bdair, et al.
Neuroscience (2025) Vol. 572, pp. 232-247
Closed Access
Orabi Hajjeh, Islam Rajab, Mohammad Bdair, et al.
Neuroscience (2025) Vol. 572, pp. 232-247
Closed Access
AGING THROUGH THE LENS OF THE GUT MICROBIOME: CHALLENGES AND THERAPEUTIC OPPORTUNITIES
N.V. Kanimozhi, M. Sukumar
Archives of Gerontology and Geriatrics Plus (2025), pp. 100142-100142
Open Access
N.V. Kanimozhi, M. Sukumar
Archives of Gerontology and Geriatrics Plus (2025), pp. 100142-100142
Open Access
Microbiome Dysbiosis as a Driver of Neurodegeneration: Insights into Alzheimer’s and Parkinson’s Diseases
Ana Jagodic, Antea Kršek, Lou Marie Salomé Schleicher, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 2, pp. 28-28
Open Access
Ana Jagodic, Antea Kršek, Lou Marie Salomé Schleicher, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 2, pp. 28-28
Open Access
Nature’s Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson’s Disease
Kételin Vitória Matias, V Gonçalves, Fulvio Alexandre Scorza, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1672-1672
Open Access
Kételin Vitória Matias, V Gonçalves, Fulvio Alexandre Scorza, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1672-1672
Open Access
Dissecting the association between gut microbiota and hypertrophic scarring: a bidirectional Mendelian randomization study
Kaikai Xue, Guojian Zhang, Zihao Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Kaikai Xue, Guojian Zhang, Zihao Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Implications of Butyrate Signaling Pathways on the Motor Symptomatology of Parkinson’s Disease and Neuroprotective Effects—Therapeutic Approaches: A Systematic Review
Jorge Missiego-Beltrán, Eva María Olalla-Álvarez, Ana González-Brugera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8998-8998
Open Access | Times Cited: 3
Jorge Missiego-Beltrán, Eva María Olalla-Álvarez, Ana González-Brugera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8998-8998
Open Access | Times Cited: 3
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
Tingting Luo, Qingya Che, Ziyi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Tingting Luo, Qingya Che, Ziyi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Gut microbiota’s role in glioblastoma risk, with a focus on the mediating role of metabolites
Junqing Yan, Bo Li, Chun R. Luo
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Junqing Yan, Bo Li, Chun R. Luo
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Pesticides and the Gut Microbiota: Implications for Parkinson’s Disease
Nabanita Ghosh, Krishnendu Sinha, Parames C. Sil
Chemical Research in Toxicology (2024) Vol. 37, Iss. 7, pp. 1071-1085
Closed Access | Times Cited: 2
Nabanita Ghosh, Krishnendu Sinha, Parames C. Sil
Chemical Research in Toxicology (2024) Vol. 37, Iss. 7, pp. 1071-1085
Closed Access | Times Cited: 2
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects
Ashutosh Pareek, R. L. Singhal, Aaushi Pareek, et al.
Life Sciences (2024) Vol. 355, pp. 123010-123010
Open Access | Times Cited: 2
Ashutosh Pareek, R. L. Singhal, Aaushi Pareek, et al.
Life Sciences (2024) Vol. 355, pp. 123010-123010
Open Access | Times Cited: 2
The role of gut-derived short-chain fatty acids in Parkinson's disease
Mohamed J. Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, et al.
Neurogenetics (2024) Vol. 25, Iss. 4, pp. 307-336
Closed Access | Times Cited: 2
Mohamed J. Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, et al.
Neurogenetics (2024) Vol. 25, Iss. 4, pp. 307-336
Closed Access | Times Cited: 2
Microbiome-based therapeutics for Parkinson's disease
Adam M. Hamilton, Ian N Krout, Alexandria C. White, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00462-e00462
Closed Access | Times Cited: 2
Adam M. Hamilton, Ian N Krout, Alexandria C. White, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00462-e00462
Closed Access | Times Cited: 2
